alzheimers

NICE rejects groundbreaking Alzheimer’s drugs: What it means for the UK
Featured, Insights

NICE rejects groundbreaking Alzheimer’s drugs: What it means for the UK

In a move that has triggered disappointment across the [...]

By Beena Mistry|2025-06-19T14:15:55+01:0019 June 2025|Featured, Insights|

A new era in Alzheimer’s diagnosis: What the FDA’s first approved blood test means for the UK
Insights

A new era in Alzheimer’s diagnosis: What the FDA’s first approved blood test means for the UK

On 16 May 2025, the U.S. Food and Drug [...]

By Beena Mistry|2025-05-21T16:37:48+01:0021 May 2025|Insights|

Global Headquarters
London
+ 44 (0)20 3770 7535
[email protected]

Middle East Office
Riyadh
[email protected]

Sign up for our latest insights

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.